Aaron Shiloh, MD, FSIR takes great pride in his ability to diagnose and treat medical conditions ranging from the simplest to the most complex. As one of the premier interventionalists in the tri state area, Dr. Shiloh has spent his career using minimally invasive techniques to manage various diseases. Dr. Shiloh is expert in all aspects of treatment of vascular conditions with a particular interest in venous diseases.
Aaron Shiloh, MD, FSIR began his education at the Pennsylvania State University where he earned a Bachelor of Science in Premedicine with distinction. He earned an honors degree through the Schreyer Scholars program through additional classes and by writing an honors thesis on the role of Phosphodiesterase Type IV in the regulation of the canine basilar artery.
Aaron matriculated to the University of Pennsylvania School of medicine where he earned AOA honors graduating in the top 10% of his class. After a year of general surgery internship at the Hospital of the University of Pennsylvania, he moved on to a residency in radiology at Thomas Jefferson University Hospital. After serving as chief resident, he completed a cardiovascular and interventional radiology fellowship also at Thomas Jefferson Hospital.
Aaron Shiloh, MD, FSIR, is double board certified in radiology and interventional radiology (IR). Dr. Shiloh was recently awarded fellowship in the society of interventional radiology, a distinction granted to only 10% of all doctors in this field.
Dr Shiloh has served his group in multiple capacities and has been the section chief of IR for over 5 years managing multiple hospitals and physicians. He has been elected to the leadership of the Philadelphia Angiography and Interventional Radiology Society serving as Secretary/Treasurer, Vice President, and President.
In the Media
Dr Shiloh has developed a reputation as an extraordinary physician in the Philadelphia and tri state area. He has been featured in the IR quarterly. Locally, Dr. Shiloh was featured on the local abc and nbc affiliates regarding cutting edge treatments for venous disease and women’s health.